Reasons for Discordance between 68Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate Cancer

Author:

Wang Jade1,O’Dwyer Elisabeth2,Martinez Zuloaga Juana2,Subramanian Kritika2,Hu Jim C.3,Jhanwar Yuliya S.2,Nagar Himanshu4ORCID,RoyChoudhury Arindam5,Babich John6,Huicochea Castellanos Sandra2,Osborne Joseph R.2,Margolis Daniel J. A.2ORCID

Affiliation:

1. Department of Internal Medicine, New York-Presbyterian Hospital, New York, NY 10065, USA

2. Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA

3. Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA

4. Department of Radiation Oncology, Weill Cornell Medical College, New York, NY 10065, USA

5. Department of Population Health Sciences, Weill Cornell Medical College, New York, NY 10065, USA

6. Ratio Therapeutics, Inc., Boston, MA 02210, USA

Abstract

Background: PSMA PET has emerged as a “gold standard” imaging modality for assessing prostate cancer metastases. However, it is not universally available, and this limits its impact. In contrast, whole-body MRI is much more widely available but misses more lesions. This study aims to improve the interpretation of whole-body MRI by comparing false negative scans retrospectively to PSMA PET. Methods: This study was a retrospective sub-analysis of a prospectively collected database of patients who participated in a clinical trial of PSMA PET/MRI comparing PSMA PET and whole-body MRI from 2018–2021. Subjects whose separately read PSMA PET and MRI diagnostic reports showed discrepancies (“false negative” MRI cases) were selected for sub-analysis. The cases were reviewed by the same attending radiologist who originally read the scans. The radiologist noted specific features on MRI indicating metastatic disease that were initially missed. Results: Of 263 cases, 38 (14%) met the inclusion criteria and were reviewed. Six classes of mpMRI false negatives were identified: anatomically normal (18, 47%), atypical MRI appearance (6, 16%), mischaracterization (1, 3%), undercall (6, 16%), obscured (4, 11%), and no abnormality on MRI (3, 8%). Considering that the atypical and undercalled cases could have been adjusted in retrospect, and that 4 additional cases had positive lesions to the same extent and 11 further cases had disease confined to the pelvis, only 11 (4%) of the original 263 would have had disease outside of a conventional radiation treatment plan. Conclusion: Notably, almost 50% of the cases, including most lymph node metastases, were anatomically normal using standard criteria. This suggests that current anatomic criteria for evaluating prostate cancer lymph node metastases are not ideal, and there is a need for improved criteria. In addition, 32% of cases involved some element of human interpretive error, and, therefore, improving reader training may lead to more accurate results.

Publisher

MDPI AG

Reference25 articles.

1. Cancer Statistics, 2021;Siegel;CA Cancer J. Clin.,2021

2. (2021, September 25). American Society of Clinical Oncology Prostate Cancer Statistics. Available online: https://www.cancer.net/cancer-types/prostate-cancer/statistics.

3. Conventional treatments of localized prostate cancer;Zerbib;Urology,2008

4. The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer;Berry;Urology,2005

5. The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy;Zumsteg;Eur. Urol.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3